News Daily News PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis Caitlin E. Cox August 15, 2019
News Industry News FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease July 15, 2019